SCHEMBL20129147

SCHEMBL20129147

Cn1c2ccncc2c2ccc(-c3ccc(O[C@H]4C[C@H](OCCOc5ccc(OC6CN(C(=O)OC(C)(C)C)C6)nc5)C4)nc3)cc21

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FAAH O00519 8/20 0.41
BTK Q06187 1/20 0.36
SGMS2 Q8NHU3 1/20 0.35
PIK3CD O00329 2/20 0.35
TBK1 Q9UHD2 1/20 0.33
PIK3CA P42336 1/20 0.33
GPR119 Q8TDV5 4/20 0.33
TNF P01375 1/20 0.33
CACNB4 O00305 1/20 0.33
CACNA1A O00555 1/20 0.33
CACNA1G O43497 1/20 0.33
CACNG3 O60359 1/20 0.33
CACNA1F O60840 1/20 0.33
CACNA1H O95180 1/20 0.33
CACNB3 P54284 1/20 0.33
CACNA2D1 P54289 1/20 0.33
CACNG7 P62955 1/20 0.33
CACNA1B Q00975 1/20 0.33
CACNA1D Q01668 1/20 0.33
CACNB1 Q02641 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20129160 0.92 FAAH (0.37) FAAHBTKSGMS2PIK3CDTBK1
SCHEMBL27097899 0.90 SGMS2 (0.37) FAAHBTKSGMS2PIK3CDTBK1
SCHEMBL29547814 0.90 SGMS2 (0.37) FAAHBTKSGMS2PIK3CDTBK1
SCHEMBL27152337 0.90 SGMS2 (0.37) FAAHBTKSGMS2PIK3CDTBK1
SCHEMBL20129045 0.90 SGMS2 (0.37) FAAHBTKSGMS2PIK3CDTBK1
SCHEMBL20129043 0.89 PIK3CD (0.41) FAAHBTKPIK3CDTBK1PIK3CA
SCHEMBL29547517 0.85 BTK (0.34) FAAHBTKSGMS2PIK3CDTBK1
SCHEMBL20120581 0.85 BTK (0.34) FAAHBTKSGMS2PIK3CDTBK1
SCHEMBL20120580 0.85 BTK (0.34) FAAHBTKSGMS2PIK3CDTBK1
SCHEMBL20129158 0.85 BTK (0.34) FAAHBTKSGMS2PIK3CDTBK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11912699-B2 Tau-protein targeting compounds and associated ARVINAS OPERATIONS, INC. (US) 2024-02-27 US disclosed
US-11912699-B2 Tau-protein targeting compounds and associated ARVINAS OPERATIONS, INC. (US) 2024-02-27 US disclosed
US-20180125821-A1 TAU-PROTEIN TARGETING PROTACS AND ASSOCIATED METHODS OF USE ARVINAS OPERATIONS, INC. 2018-05-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11912699-B2 Tau-protein targeting compounds and associated MAPT, VHL, CRBN FAAH 4345/4885BTK 2332/4885SGMS2 4756/4885
US-20180125821-A1 TAU-PROTEIN TARGETING PROTACS AND ASSOCIATED METHODS OF USE CRBN, VHL, UBQLN2 FAAH 4290/4885BTK 2394/4885SGMS2 4762/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.